Cargando…
Medullary Carcinoma of Thyroid Due to GLP-1 Receptor Agonist
Introduction: The first GLP-1 receptor agonist (GLP-1 RA) was approved for the treatment of type 2 Diabetes mellitus in 2005. This class has gained popularity due to its anti-glycemic effect, weight loss and reduction in Cardiovascular disease outcomes(1). The effects of this drug class on human thy...
Autores principales: | Vemula, Hasitha, Villanueva, Fiorella Sotomayor, Nguyen, Huong Diem, Mohan, Akhila, Potluri, Sriravali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089522/ http://dx.doi.org/10.1210/jendso/bvab048.1823 |
Ejemplares similares
-
ODP477 Ectopic Cushing's Syndrome Due to Medullary Thyroid Cancer
por: Mateen, Abdul, et al.
Publicado: (2022) -
SUN-598 Neck Pain as an Initial Presentation of Medullary Thyroid Cancer
por: Roth, Michael, et al.
Publicado: (2019) -
SUN-595 Chronic Diarrhea as a Manifestation of Medullary Thyroid Cancer
por: Shakir, Mohamed, et al.
Publicado: (2019) -
A Case of Paraneoplastic Erythropoietin Secretion Secondary to Medullary Thyroid Cancer
por: Pare, Aurelie, et al.
Publicado: (2021) -
The Difficulty of Post-Operative Surveillance of Calcitonin Negative Medullary Thyroid Cancer
por: Skutnik, Emily, et al.
Publicado: (2021)